Vertical Longevity Pharmaceuticals, Inc. is raising up to $500K on NetCapital Funding Portal Inc. in common stock at $0.97 each; in its filing revenue was $0 and it had 1 employee (Form C-AR, 2026-03-30).
Vertical Longevity Pharmaceuticals, Inc. filed a Regulation Crowdfunding offering with the SEC through NetCapital Funding Portal Inc., with a target of $10K and a maximum of $500K. As of November 6, 2026, the offering is past its deadline of January 16, 2026. The company gives its address as Irvine, CA (Form C, October 10, 2025).
Sell to companies like Vertical Longevity Pharmaceuticals, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
Vertical Longevity Pharmaceuticals, Inc., based in Irvine, CA, filed a Regulation Crowdfunding offering with the SEC, the latest on 2025-10-10, raising through NetCapital Funding Portal Inc.. It set a target of $10K and will accept up to $500K. The security offered is common stock at $0.97 each. As of its filings the offering is past its deadline of 2026-01-16. 3 filings in this family are on record for the company.
Terms at a glance
| Target | $10K |
| Maximum it will accept | $500K |
| Security | Common Stock |
| Price per unit | $0.97 (The price of the Securities was determined solely by management and bears no relation to traditional measures of valuation such as book value or price-to-earnin) |
| Units at the target | 10,310 |
| Raise above the target | accepted, first-come, first-served basis |
| Deadline | 2026-01-16 |
| Raising through | NetCapital Funding Portal Inc. |
| What the portal is paid, as filed | Up to 4.9% of amount raised for a successful offering and a listing fee of up to $10,000 |
Check before you invest in Vertical Longevity Pharmaceuticals, Inc.: who signed the filing and its own figures, free.
Free to see. No signup.
Want the whole picture on Vertical Longevity Pharmaceuticals, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Vertical Longevity Pharmaceuticals, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Vertical Longevity Pharmaceuticals, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
4 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
The filing does not state a company valuation or a minimum investment; the offering page on NetCapital Funding Portal Inc. shows those. Check both before you invest.
Money raised before
Earlier raises by this company that are on file, with the amounts as filed. A figure for a raise is what the company reported, not a check of what it received.
| Filed | What | Amount as filed | Filing |
|---|---|---|---|
| 2026-09-28 | Private placement (Form D) | $110K sold of $110K offered | filing |
Offering filings
| Filed | Intermediary | Target | Maximum | Deadline | Security | Filing |
|---|---|---|---|---|---|---|
| 2025-10-10 | NetCapital Funding Portal Inc. | $10K | $500K | 2026-01-16 | Common Stock | C |
Financials the company filed
Figures from the C-AR filed 2026-03-30, as the company reported them.
| As filed | Most recent fiscal year | Prior fiscal year |
|---|---|---|
| Revenue | $0 | $0 |
| Net income | -$19K | $0 |
| Total assets | $25 | $0 |
| Cash and equivalents | $25 | |
| Short-term debt | $0 | |
| Long-term debt | $0 |
Employees at filing: 1.
Revenue went from $0 to $0. Net loss was $19K, against $0 the year before. It reported $25 in cash and $0 in debt. These are the company's own figures from the Form C-AR filed 2026-03-30.
People who signed the filing
- David Scieszka, President
Every filing
What to check before investing
- Read the offering page on NetCapital Funding Portal Inc.: it states the valuation or cap and the minimum investment, which the SEC filing does not.
- Compare the terms above with the numbers: what does the price imply against revenue of $0?
- Look at who signed the filing and what else they have run (the founder Snapshot below).
- Check the deadline and what happens if the target is missed.
- You cannot easily sell a crowdfunding security; invest only what you can leave tied up.
A crowdfunding round is won in public. FoxPlug turns your commits, deploys and releases into the posts and visuals that keep the story moving while the offering is open.
Build your launch kitRun a Snapshot on David Scieszka: other companies, roles and the record behind them. Order Full Report from there if you need more.
Snapshot the foundersTools for this story
Each opens in a new tab, filled in for Vertical Longevity Pharmaceuticals, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A company raising money from the public under Regulation Crowdfunding has to file with the SEC before the offering opens, and has to raise through a single registered intermediary: a funding portal or a broker-dealer. The first filing, Form C, states how much the company is trying to raise, the most it will accept, the deadline, the security and its price, the intermediary and what the intermediary is paid, and two years of the company's own financial figures.
After that the company files amendments when terms change, progress updates as the raise moves, and an annual report each year until it stops reporting. Every row here is one of those filings, linked to the filing itself, so each figure can be checked at the source. Figures are exactly as the company filed them; where a filing leaves a field blank, so does this page. Nothing here is investment advice, and a filing is the company's own statement, not a verification of it.